Trial Details
UNKNOWNBasic Information
| Clinical ID | c1629 |
|---|---|
| Identifier | NCT04769258 |
| Trial Title | Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: Pfizer Comirnaty vaccine |
Participant Information
| Sponsor | Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2021-03-01 |
|---|---|
| Primary Completion Date | 2022-03-01 |
| Completion Date | 2022-06-01 |